Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

The Road to Recovery Report makes specific recommendations for maintaining the adaptations made necessary to accommodate the disruptions caused by the pandemic. Where possible, the report recommends building on that momentum to spur much-needed change in cancer care and research.
March 11, 2021 The Honorable Tom Oliverson, Chairman House Insurance Committee 1100 Congress Ave Room E2. 150 Austin, TX 78701 Dear Chair Oliverson and Members of the Committee, The Texas Society of Clinical Oncology (TxSCO) and the Association for Clinical Oncology (ASCO) are pleased to support House Bill 293: Relating to health benefit coverage for certain fertility preservation …
MEMORANDUM IN SUPPORT S5299 Rivera / A1741 Gottfried TO PREVENT HARMFUL AND UNFAIR COPAY ACCUMULATOR POLICIES New York has a strong record in leading the nation in providing access to affordable health coverage. Despite the strides the state has made in expanding coverage, many New Yorkers still face hardship when faced with prescription drug costs. New Yorkers …
National Policy Resources—Local Advocacy Results As cancer care professionals who experience the challenges of providing quality cancer care first-hand, ESHOS members are well positioned to educate decision-makers on how coverage and reimbursement issues affect community oncology. State and federal legislation can have a significant impact on the financial viability of local cancer programs, which …
Washington, D.C. (March 17, 2021) – Yesterday, a bipartisan coalition of members in the House of Representatives introduced the Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021 (H.R. 1946) in an effort to make the latest cancer screening technologies available to patients. The Association of Community Cancer Centers (ACCC) thanks Reps. Terri Sewell (D-AL), Jodey Arrington …
ACCC President Krista Nelson, MSW, LCSW, OSW-C, FAOSW, shares with us why she believes the theme of this year’s Social Work Month is important and how it ties into her own theme as ACCC’s new president.
Rockville, MD — The Association of Community Cancer Centers (ACCC) has announced its new Executive Committee leadership and new Board of Trustee members for the 2021-2022 term. David R. Penberthy, MD, MBA, Radiation Oncologist at Virginia Radiation Oncology Associates Inc., will serve as the new President-Elect of the Executive Committee, and Nadine J. Barrett, PhD, MA, MS, Director of the Office of …
On March 9, the U.S. Preventive Services Task Force (USPSTF) updated its recommendation for annual lung cancer screening. USPSTF estimates that these changes will almost double the number of at-risk individuals who are eligible for lung cancer screening.
Insurer mandates requiring patients to have their therapies dispensed via “brown bagging” or “white bagging” are becoming increasingly common. Oncologists treating patients whose insurers require these methods of pharmaceutical procurement have identified problematic issues with them, including concerns about patient safety, proper care coordination, potential treatment delays, and drug waste.
Geriatric Assessment_How To Guide ASSOCIATION OF COMMUNITY CANCER CENTERS Practical Application of Geriatric Assessment: A How-To Guide for the Multidisciplinary Care Team ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● …
The Association of Community Cancer Centers (ACCC) is the leading education and advocacy organization for the cancer care community. Founded in 1974, ACCC is a powerful network of 28,000 multidisciplinary practitioners from 2,100 hospitals and practices nationwide. As advances in cancer screening and diagnosis, treatment options, and care delivery models continue to evolve—so has ACCC—adapting …
March 11, 2021
Speakers will discuss challenges, opportunities, and pitfalls that have been encountered and how programs and practices considering changing to a value-based model approach can operationalize successfully.
I M M U N O - ONCOLOGY I N S T I T U T E ASSOCIATION OF COMMUNITY CANCER CENTERS The Association of Community Cancer Centers (ACCC) is the leading education and advocacy organization for the cancer care community. Founded in 1974, ACCC is a powerful network of 28,000 multidisciplinary practitioners from 2,100 hospitals and practices nationwide. As advances in cancer screening …
Caring for patients experiencing toxicities from treatment with immune checkpoint inhibitors (ICIs) requires multidisciplinary input and coordination. Rheumatologists evaluate and treat patients experiencing a wide variety of immune-related adverse events (irAEs), including inflammatory arthritis, sicca syndrome, polymyalgia rheumatica, myositis, vasculitis, and scleroderma. It’s important for rheumatologists …
While immuno-oncology (IO) therapies have heralded significant advancements in cancer care, there are still many unknowns when it comes to the long-term side effects of these relatively new agents. Since ambulatory care typically involves long-term chronic disease management, these unknowns can often translate to management uncertainty.
The Association of Community Cancer Centers (ACCC) is the leading education and advocacy organization for the cancer care community. Founded in 1974, ACCC is a powerful network of 28,000 multidisciplinary practitioners from 2,100 hospitals and practices nationwide. As advances in cancer screening and diagnosis, treatment options, and care delivery models continue to evolve—so has ACCC—adapting …
The positive impacts of IO therapy are remarkable, the era of IO has also ushered in new challenges. The efficacy of IO has led to a growing population of patients living with and beyond cancer. This has challenged original concepts of survivorship care, starting with the very definition of “survivorship.”
Disease Drug Company Therapeutic Role Type of Drug Diagnostic Test Specified Approval Type Medicare Payment Category Margenza (margetuximab- cmkb ) Macrogenics Third-line for metastatic, HER2+ disease HER2-neu receptor antagonist None Full Part B Phesgo (pertuzumab, trastuzumab, hyaluronidase- zzxf ) Genentech Neoadjuvant for HER2+ early BC, adjuvant for high risk …
OI | Vol. 36, No. 2, 2021 | accc-cancer.org 11 S t. Elizabeth Cancer Care is an outpatient department of St. Elizabeth Healthcare, a large multi-hospital system. The cancer program treats approximately 300,000 patients annually across four hospital-based locations in rural and urban communities in northern Kentucky and southern Indiana. St. Elizabeth Cancer Care opened the doors to …
Read about this model that engages oncology stakeholders in advancing biomarker testing and application into practice, increasing access to state-of-the-art genomic testing and clinical trials.